Literature DB >> 11684849

Upper tract transitional cell carcinoma following cystectomy for bladder cancer.

J Huguet-Pérez1, J Palou, F Millán-Rodríguez, J Salvador-Bayarri, H Villavicencio-Mavrich, J Vicente-Rodríguez.   

Abstract

PURPOSE: We assessed the incidence of upper urinary tract tumors (UUTTs) after cystectomy for invasive or superficial transitional cell carcinoma (TCC) of the bladder. The risk factors, patients' characteristics and evolution of those who developed UUTTs are analyzed.
MATERIALS AND METHODS: From August 1980 to February 1994, 568 radical cystectomies were performed for TCC of the bladder: in 469 instances (82.5%) due to invasive tumor (T2-T4), and in 99 cases (17.5%) for superficial tumor (Ta, T1, Tis). All patients were followed for at least 5 years or until death. A retrospective study of patients who developed UUTTs has been performed. A revision of bladder tumor and UUTT characteristics, and the intervals between both is also evaluated.
RESULTS: 26 patients (4.5%) developed UUTTs: 11 of the 99 patients cystectomized for superficial TCCs (11.1%); 6 of the 392 patients with primary invasive TCC (1.5%), and 9 of the 77 (11.6%) patients with invasive tumors and a prior history of superficial TCC. The interval to the development of UUTT was higher after cystectomy for superficial tumor. TCCs of the bladder that subsequently developed UUTTs were high grade in 84%, multifocal in 80%, or had carcinoma in situ in 65%, tumor in the prostatic urethra in 52%, and involvement of the distal ureter in 57%. Twenty-two UUTTs (84%) were located in the calyces or the renal pelvis, 3 were bilateral (11.5%), 14 multiple (58%) and 4 superficial (16%). With a median follow-up time of 18 (range 3-103) months, 14 patients (53.8%) died of tumor, 2 were alive with disease, 2 were lost for follow-up, and 8 (30%) were alive and free of disease.
CONCLUSIONS: We found that patients cystectomized for superficial or invasive TCC with a prior history of superficial TCC have a higher incidence of UUTTs. These cases require follow-up with annual urography or loopography.

Entities:  

Mesh:

Year:  2001        PMID: 11684849     DOI: 10.1159/000049793

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  14 in total

Review 1.  Current management of muscle-invasive bladder cancer.

Authors:  G Sancho; P Maroto; J Palou
Journal:  Clin Transl Oncol       Date:  2011-12       Impact factor: 3.405

Review 2.  Staged based directed surveillance of invasive bladder cancer following radical cystectomy: valuable and effective?

Authors:  S Machele Donat
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

3.  Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study.

Authors:  Philipp Nuhn; Giacomo Novara; Christian Seitz; Amit Gupta; Kazumasa Matsumoto; Wassim Kassouf; Thomas J Walton; Hans-Martin Fritsche; Stefan Tritschler; Juan I Martínez-Salamanca; Vincenzo Ficarra; Pierre I Karakiewicz; Guido Mazzoleni; Shahrokh F Shariat; Patrick J Bastian
Journal:  World J Urol       Date:  2014-07-22       Impact factor: 4.226

4.  Intraoperative frozen section evaluation of ureteral and urethral margins: studies of 203 consecutive radical cystoprostatectomy for men with bladder urothelial carcinoma.

Authors:  Haijun Zhou; Jae Y Ro; Luan D Truong; Alberto G Ayala; Steven S Shen
Journal:  Am J Clin Exp Urol       Date:  2014-07-12

5.  Surveillance strategies after definitive therapy of invasive bladder cancer.

Authors:  Ilias Cagiannos; Christopher Morash
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

6.  Shared occupational risks for transitional cell cancer of the bladder and renal pelvis among men and women in Sweden.

Authors:  Robin Taylor Wilson; Mark Donahue; Gloria Gridley; Johanna Adami; Laure El Ghormli; Mustafa Dosemeci
Journal:  Am J Ind Med       Date:  2008-02       Impact factor: 2.214

Review 7.  Radical Cystectomy in Female Patients - Improving Outcomes.

Authors:  Nikolaos Kalampokis; Nikolaos Grivas; Markus Ölschläger; Fahmy Nabil Hassan; Georgios Gakis
Journal:  Curr Urol Rep       Date:  2019-11-28       Impact factor: 3.092

8.  Simultaneous Cystectomy and Nephroureterectomy due to Synchronous Upper Urinary Tract Tumors and Invasive Bladder Cancer: Open and Laparoscopic Approaches.

Authors:  Manuel Pérez-Utrilla Pérez; Alfredo Aguilera Bazán; José M Alonso Dorrego; Rebeca Vitón Herrero; Jesús Cisneros Ledo; Javier de la Peña Barthel
Journal:  Curr Urol       Date:  2012-09-27

9.  Monitoring of the upper urinary tract in patients with bladder cancer.

Authors:  Rajinikanth Ayyathurai; Mark S Soloway
Journal:  Indian J Urol       Date:  2011-04

10.  Endourologic management of upper tract transitional cell carcinoma following cystectomy and urinary diversion.

Authors:  Jeffrey John Tomaszewski; Marc Christopher Smaldone; Michael Cecil Ost
Journal:  Adv Urol       Date:  2008-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.